BiotechTube

Next Generation Emulsion Preservative Free Eye Drops (NGE-UD)

Pre-clinicalCompleted
0 watching 0 views this week💤 Quiet
23
Hype Score

Development Stage

1
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Dry Eye

Conditions

Dry Eye

Trial Timeline

Jun 17, 2024 → Oct 14, 2024

NCT ID
NCT06443775

About Next Generation Emulsion Preservative Free Eye Drops (NGE-UD)

Next Generation Emulsion Preservative Free Eye Drops (NGE-UD) is a pre-clinical stage product being developed by AbbVie for Dry Eye. The current trial status is completed. This product is registered under clinical trial identifier NCT06443775. Target conditions include Dry Eye.

Hype Score Breakdown

Clinical
5
Activity
2
Company
10
Novelty
2
Community
1

Clinical Trials (1)

NCT IDPhaseStatus
NCT06443775Pre-clinicalCompleted

Competing Products

20 competing products in Dry Eye

See all competitors
ProductCompanyStageHype Score
Cyclosporine Ophthalmic 0.05% Ophthalmic EmulsionSight SciencesPre-clinical
15
OK-101 + PlaceboOKYO PharmaPhase 2
44
ISV 101Sun PharmaceuticalPhase 2
52
CequaTM (Cyclosporine 0.09%) ophthalmic solutionSun PharmaceuticalApproved
85
0.09% cyclosporine A ophthalmic solutionSun PharmaceuticalPre-clinical
23
Cyclosporine + Artificial tearSun PharmaceuticalApproved
85
nanomicellular cyclosporine 0.09% + LifitegrastSun PharmaceuticalApproved
85
Cyclosporine 0.09% Ophthalmic SolutionSun PharmaceuticalApproved
85
Investigational Lubricating Eye Drop in a Novelia® bottle + Blink® Tears eye DropsJohnson & JohnsonPhase 2
52
diquafosol ophthalmic solution + 0.1% sodium hyaluronate ophthalmic solution.Santen PharmaceuticalPre-clinical
23
Diquafosol sodium 3% + Sodium hyaluronate 0.1%Santen PharmaceuticalPhase 2
52
3% DE-089 ophthalmic solution + 0.1% sodium hyaluronate ophthalmic solutionSanten PharmaceuticalPhase 3
77
Placebo ophthalmic solution and 3% DE-089 ophthalmic solutionSanten PharmaceuticalPhase 1
33
DE-089 ophthalmic solution + DE-089 ophthalmic solution + Placebo ophthalmic solutionSanten PharmaceuticalPhase 2
52
SHR8028 eye drops + Vehicle eye drops.Jiangsu Hengrui MedicinePhase 3
77
SHR8058 eye drops + saline eye drops.Jiangsu Hengrui MedicinePhase 3
77
ABBV-444 + REFRESH OPTIVE UDAbbViePhase 3
77
AGN-242428 + AGN-231868 + Lifitegrast 5% Ophthalmic SolutionAbbViePhase 1/2
41
ABBV-444AbbViePhase 3
77
ABBV-319AbbViePhase 1
33

Other Products from AbbVie

Pancrelipase + PancrelipaseApproved
85
CREONApproved
85
Venetoclax + AzacitidineApproved
85
Oxybutynin + PlaceboApproved
85
Glecaprevir-pibrentasvirApproved
85